Skip to main content
Watch Insiders
ARQTHealthcare

Arcutis Biotherapeutics Inc (ARQT) Insider Trading

In the last 90 days, 5 Arcutis Biotherapeutics Inc (ARQT) insiders reported no open-market purchases and 12 sales totaling $2,303,448. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Oct 15, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 15, 2026Howard G. WelgusCorporate insiderSale4,728$26.93$127,325
Sep 16, 2026Masaru MatsudaSee RemarksSale3,674$25.00$91,853
Sep 15, 2026Howard G. WelgusCorporate insiderSale4,730$24.18$114,371
Sep 8, 2026Masaru MatsudaSee RemarksSale9,989$25.03$249,986
Aug 27, 2026Terrie CurranCorporate insiderSale38,200$25.03$956,123
Aug 20, 2026Terrie CurranCorporate insiderSale1,072$26.04$27,912
Aug 19, 2026Patrick BurnettSee RemarksSale1,697$27.00$45,819
Aug 17, 2026Howard G. WelgusCorporate insiderSale4,730$26.18$123,835
Aug 12, 2026Patrick BurnettSee RemarksSale15,000$26.33$394,898
Aug 3, 2026Patrick BurnettSee RemarksSale955$26.12$24,942
🔒 Create Free Insider Alerts — Join Watch Insiders

Common questions

ARQT insider trading FAQ

Are ARQT insiders buying or selling?
Over the last 90 days, ARQT insiders were net sellers, reporting $0.00 of open-market purchases and $2,303,448 of sales.
When was the last ARQT insider purchase?
No open-market insider purchase of Arcutis Biotherapeutics Inc stock was reported in the last 90 days.
Where does ARQT insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Arcutis Biotherapeutics Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.